Anderson Hoagland & CO Bristol Myers Squibb CO Transaction History

Anderson Hoagland & CO

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 25, 2022	SELL	$53.63 - $62.52 $3.78 Million - $4.4 Million	-70,426 Closed	0 $0
Q3 2021 Oct 07, 2021	BUY	$59.17 - $69.31 $29,585 - $34,655	500 Added 0.72%	70,426 $4.17 Million
Q2 2021 Jul 19, 2021	BUY	$61.91 - $67.42 $248,011 - $270,084	4,006 Added 6.08%	69,926 $4.67 Million
Q1 2021 Apr 09, 2021	BUY	$59.34 - $66.74 $113,576 - $127,740	1,914 Added 2.99%	65,920 $4.16 Million
Q4 2020 Feb 03, 2021	BUY	$57.74 - $65.43 $1.52 Million - $1.72 Million	26,326 Added 69.87%	64,006 $3.97 Million
Q3 2020 Oct 06, 2020	SELL	$57.43 - $63.64 $60,301 - $66,822	-1,050 Reduced 2.71%	37,680 $2.22 Million
Q2 2020 Jul 06, 2020	BUY	$54.82 - $64.09 $18,364 - $21,470	335 Added 0.87%	38,730 $2.28 Million
Q1 2020 Apr 23, 2020	BUY	$46.4 - $67.43 $310,880 - $451,781	6,700 Added 21.14%	38,395 $1.9 Million
Q4 2019 Jan 06, 2020	BUY	$49.21 - $64.19 $1.56 Million - $2.03 Million	31,695 New	31,695 $1.81 Million

2,533

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $120B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Anderson Hoagland & CO, based on Form 13F filings with the SEC.

Stay updated on Anderson Hoagland & CO with notifications on news.